Sotalol IV (sotalol hydrochloride injection 15 mg/mL for intravenous use) offers flexibility, control, and speed, so patients may avoid inconvenient hospitalization days.
Sotalol hydrochloride for intravenous use is an antiarrhythmic agent indicated for substitution for oral sotalol in patients who are unable to take sotalol orally.
See below for pediatric dosing guidance.
Recommended per Guidelines
The American Heart Association (AHA) recommends use of Sotalol IV in its Guidelines for Cardiopulmonary Resuscitation & Emergency Cardiovascular Care.1
AltaThera was recently selected by the FDA for a new regulatory program. This program allows for an accelerated pathway to develop new dosing for adult atrial fibrillation.
Sotalol IV dose should be reduced by a factor that depends on age.